Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Sep;41(9):2019–2022. doi: 10.1128/aac.41.9.2019

Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004).

L M Ednie 1, M R Jacobs 1, P C Appelbaum 1
PMCID: PMC164057  PMID: 9303406

Abstract

HMR 3647 (RU 66647) and HMR 3004 (RU 64004), two ketolides, had MICs at which 50% of the strains are inhibited (MIC50s) of 0.06 to 0.125 microg/ml and MIC90s of 16.0 microg/ml against 352 anaerobes. MIC50s and MIC90s of erythromycin, azithromycin, clarithromycin, and roxithromycin were 0.5 to 2.0 microg/ml and 32.0 to >64.0 microg/ml, respectively. HMR 3647 and HMR 3004 were more active against non-Bacteroides fragilis-group anaerobes (other than Fusobacterium mortiferum, Fusobacterium varium, and Clostridium difficile).

Full Text

The Full Text of this article is available as a PDF (168.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. George W. L., Kirby B. D., Sutter V. L., Citron D. M., Finegold S. M. Gram-negative anaerobic bacilli: Their role in infection and patterns of susceptibility to antimicrobial agents. II. Little-known Fusobacterium species and miscellaneous genera. Rev Infect Dis. 1981 May-Jun;3(3):599–626. doi: 10.1093/clinids/3.3.599. [DOI] [PubMed] [Google Scholar]
  2. Jamjian C., Biedenbach D. J., Jones R. N. In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004. Antimicrob Agents Chemother. 1997 Feb;41(2):454–459. doi: 10.1128/aac.41.2.454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Jones R. N., Biedenbach D. J. Antimicrobial activity of RU-66647, a new ketolide. Diagn Microbiol Infect Dis. 1997 Jan-Feb;27(1-2):7–12. doi: 10.1016/s0732-8893(96)00181-2. [DOI] [PubMed] [Google Scholar]
  4. Schülin T., Wennersten C. B., Moellering R. C., Jr, Eliopoulos G. M. In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria. Antimicrob Agents Chemother. 1997 May;41(5):1196–1202. doi: 10.1128/aac.41.5.1196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Spangler S. K., Appelbaum P. C. Oxyrase, a method which avoids CO2 in the incubation atmosphere for anaerobic susceptibility testing of antibiotics affected by CO2. J Clin Microbiol. 1993 Feb;31(2):460–462. doi: 10.1128/jcm.31.2.460-462.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Spangler S. K., Jacobs M. R., Appelbaum P. C. Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin. Antimicrob Agents Chemother. 1994 Feb;38(2):211–216. doi: 10.1128/aac.38.2.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Spangler S. K., Jacobs M. R., Appelbaum P. C. Susceptibilities of 201 anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin by oxyrase agar dilution and E test methodologies. J Clin Microbiol. 1995 May;33(5):1366–1367. doi: 10.1128/jcm.33.5.1366-1367.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES